Qutenza Overview

  • Status

  • Acquired/​Merged

  • Latest Deal Type

  • Asset Purch.

  • Financing Rounds

  • 2

Qutenza General Information

Description

Portfolio of a pharmaceutical drugs and its global commercial rights based in Morristown, New Jersey. The asset portfolio consists of Qutenza (capsaicin) 8% patch, a dermal delivery system containing prescription strength capsaicin, which is used for management of neuropathic pain associated with postherpetic neuralgia.

Contact Information

Website
www.qutenza.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Grünenthal
Primary Office
  • 360 Mount Kemble Avenue
  • 3rd Floor, Suite 3
  • Morristown, NJ 07960
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Qutenza Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Qutenza‘s full profile, request access.

Request a free trial

Qutenza Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Qutenza‘s full profile, request access.

Request a free trial